Prevalence of dementia, heart disease and stroke in community-dwelling adults in Canada, 2016–2021: opportunities for joint prevention

[11] van der Hofman A(2021)Regional and socioeconomic disparities in cardiovascular disease in Canada during 2005–2016: evidence from repeated nationwide cross-sectional surveys BMJ Global Health 6 e006809-10

[12] Rolandi E(2020)Recent trends in hospitalizations for cardiovascular disease, stroke, and vascular cognitive impairment in Canada Can J Cardiol 36 1081-64

[13] Zaccaria D(2022)Trends in prevalence of self-reports of Alzheimer’s disease/dementia among non-institutionalized individuals 45 + in Canada, 1994–2014 J Public Health Res 11 22799036221135221-50

[14] Vaccaro R(2016)Alzheimer’s and other dementias in Canada, 2011 to 2031: a microsimulation Population Health modeling (POHEM) study of projected prevalence, health burden, health services, and caregiving use Popul health metrics 14 1-6

[15] Abbondanza S(2022)Secular trends of ischaemic heart disease, stroke, and dementia in high-income countries from 1990 to 2017: the global burden of Disease Study 2017 Neurol Sci 43 255-8

[16] Pettinato L(2018)Cardiovascular disease patients have increased risk for comorbidity: a cross-sectional study in the Netherlands Eur J Gen Pract 24 45-9

[17] Davin A(2020)Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK Heart 106 810-6

[18] Hachinski V(2017)Atrial fibrillation as a risk factor for cognitive decline and dementia Eur Heart J 38 2612-93

[19] Einhäupl K(2019)Post stroke depression and risk of stroke recurrence and mortality: a systematic review and meta-analysis Ageing Res Rev 50 102-62

[20] Ganten D(2018)Sex and gender differences in Alzheimer’s disease dementia The Psychiatric times 35 14-35

[11] van der Hofman A(2021)Regional and socioeconomic disparities in cardiovascular disease in Canada during 2005–2016: evidence from repeated nationwide cross-sectional surveys BMJ Global Health 6 e006809-10

[12] Rolandi E(2020)Recent trends in hospitalizations for cardiovascular disease, stroke, and vascular cognitive impairment in Canada Can J Cardiol 36 1081-64

[13] Zaccaria D(2022)Trends in prevalence of self-reports of Alzheimer’s disease/dementia among non-institutionalized individuals 45 + in Canada, 1994–2014 J Public Health Res 11 22799036221135221-50

[14] Vaccaro R(2016)Alzheimer’s and other dementias in Canada, 2011 to 2031: a microsimulation Population Health modeling (POHEM) study of projected prevalence, health burden, health services, and caregiving use Popul health metrics 14 1-6

[15] Abbondanza S(2022)Secular trends of ischaemic heart disease, stroke, and dementia in high-income countries from 1990 to 2017: the global burden of Disease Study 2017 Neurol Sci 43 255-8

[16] Pettinato L(2018)Cardiovascular disease patients have increased risk for comorbidity: a cross-sectional study in the Netherlands Eur J Gen Pract 24 45-9

[17] Davin A(2020)Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK Heart 106 810-6

[18] Hachinski V(2017)Atrial fibrillation as a risk factor for cognitive decline and dementia Eur Heart J 38 2612-93

[19] Einhäupl K(2019)Post stroke depression and risk of stroke recurrence and mortality: a systematic review and meta-analysis Ageing Res Rev 50 102-62

[20] Ganten D(2018)Sex and gender differences in Alzheimer’s disease dementia The Psychiatric times 35 14-35